Biomedtech News

Caranx Medical announces FDA submission of TAVIPILOT Soft

January 13, 2025

Caranx Medical, a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced FDA submission of the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.

The FDA submission marks a significant milestone of Caranx strategy towards planned market introduction of TAVIPILOT Soft by end of 2025.

Caranx Medical

Autonomous robot improving efficiency and safety in Transcatheter Aortic Valve Replacement (TAVI...

ALSO TO BE DISCOVERED

November 17, 2024

Philippe Pouletty, CEO and co-founder of Truffle Capital, is a guest on Figaro TV

October 23, 2024

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners

July 17, 2024

New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic

July 12, 2024

Affluent Medical signs agreements for mitral valve technologies with €15M upfront payment

April 16, 2024

SpikImm Announces an Exclusive License with SATT Conectus for the Development of a Prophylactic mAb Against BK Virus

April 16, 2024

Caranx Medical, announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal

April 4, 2024

Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.

March 12, 2024

Interview of Philippe Pouletty regarding the firtst successful Artus in-human implantation

February 26, 2024

PK MED Announces FDA Clearance to Initiate its Clinical Programme for PKM-01, for Local Treatment of Gout Flares, Directly by Phase II Trial

February 16, 2024

Minister Bruno Le Maire visits Carbios and expresses full support